Delivery Order SPE2DB22D2206-SPE2DB25FJL29
Award Date 8/15/25
Potential Completion Date 9/8/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,262.85 to AmerisourceBergen Drug Corp for the supply of IMFINZI (500 mg/10 mL vial, 10 mL). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded, non-set-aside procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. IMFINZI is an oncology medication used in cancer...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $23,873.13 for IMFINZI 500 mg/10 mL vials under a firm fixed-price contract with the Defense Department's Medical Supply Chain. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. IMFINZI is a prescription oncology medication, and this order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,830.84 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed-price delivery order, with completion targeted for September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a $25,097.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562071741 IMFINZI 500 MG/10 ML VIAL 10ML. This order is being issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified vials of IMFINZI, an anti-PD-L1 antibody medication, from its facility in Conshohocken, Pennsylvania to an unknown customer by...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,130 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,742,216 units of the oncology medication IMFINZI (500 mg/10 mL vial, 10 mL). This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The award has a ceiling value of $31,830.84 and a completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp represents a $1,903.44 firm fixed-price contract for IMFINZI 120 mg/2.4 ml vials to be delivered by August 21, 2025. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm, with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for Imfinzi 500 mg/10 mL vials on July 31, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 mg/10 ml vials, with a ceiling value of $2,652.57 and an ultimate completion date of June 13, 2025. The contract is not set-aside and is awarded as a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...